Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

706 articles

Showing 49–72 of 76 articles · Keyword: Endosomal escape Clear keyword

Advanced Drug Delivery Reviews.2016ReviewNon-viral Gene Delivery

49. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery

Cheng X, Lee Rj

Oligonucleotide (ON) therapeutics—antisense ONs, siRNA, miRNA mimics/inhibitors, antimiRs—are limited by poor membrane permeability, rapid renal/RES clearance, and nuclease degradation. LNPs can protect ONs and improve delivery, but the role of helper lipids in LNP stability, circulation, endosomal escape, and in…

Read the article
Journal of Controlled Release 200 (2015ResearchNon-viral Gene Delivery

50. A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma

H. Akita Et Al.

Cationic gene carriers can mediate cellular uptake but often show poor post-nuclear transcription/translation, toxicity, and aggregation in blood. The study aimed to develop a systemically applicable, tumour-targeting gene carrier that is neutral in blood/cytosol but becomes cationic in endosomes for endosomal…

Read the article
Journal of Controlled Release.2015ReviewNon-viral Gene Delivery

51. Solid lipid nanoparticles as nucleic acid delivery system Properties and molecular mechanisms

De Jesus Mb, Zuhorn Is

Non-viral nucleic acid delivery requires carriers that protect DNA/RNA from nucleases and facilitate intracellular delivery. Solid lipid nanoparticles (SLNs) are promising, but the molecular mechanisms by which they assemble with nucleic acids, transfect cells, and release cargo remain poorly understood compared with…

Read the article
Macromolecular Bioscience2015ReviewNon-viral Gene Delivery

52. Defined Polymeric Materials for Gene Delivery

He, D.; Wagner, E

Polymeric gene delivery carriers such as PEI and poly(L-lysine) are heterogeneous and polydisperse, making site-specific multifunctional modification, structure–activity relationship studies, and reproducible clinical manufacturing difficult. This review argues that precisely defined polymeric materials — dendrimers…

Read the article
Nanoscale2014ReviewNon-viral Gene Delivery

53. Enhancing Endosomal Escape for Nanoparticle Mediated siRNA Delivery

Da Ma

siRNA-based gene therapy is a promising biotechnology for treating cancer and other diseases, but safe and efficient delivery is essential. Nanoparticle-mediated delivery must overcome multiple biological barriers, and endosomal escape is a critical rate-limiting barrier: nanoparticles are typically internalised via…

Read the article
Polymers for Advanced Technologies (Polym. Adv. Technol.)2014ResearchNon-viral Gene Delivery

54. Bioreducible Polyspermine as Less Toxic and Efficient Gene Carrier

Hongsuk Park, Joseph W. Nichols, Han Chang Kang, You Han Bae

Bioreducible polymers are attractive as gene carriers because they can reduce cytotoxicity compared with non-degradable cationic polymers such as polyethyleneimine (PEI). However, the safety and transfection efficiency of spermine-based bioreducible polyspermines had not been directly compared with linear PEI (lPEI)…

Read the article
Biochimica et Biophysica Acta (BBA) - Biomembranes2013ResearchNon-viral Gene Delivery

55. Modeling the endosomal escape of cell-penetrating peptides using a transmembrane pH gradient

Fatemeh Madani, Rania Abdo, Staffan Lindberg, Hisaaki Hirose, Shiroh Futaki, Ulo Langel, Astrid Gräslund

Cell-penetrating peptides (CPPs) can internalise cells with biologically active cargo, but endosomal entrapment is a major limitation for cytoplasmic delivery, as cargo molecules must escape the endosome before degradation and acidification. While CPPs are known to enter cells via endocytosis, the background…

Read the article
ACS Applied Materials & Interfaces (Just Accepted Manuscript)2013ResearchNon-viral Gene Delivery

56. (3-Aminopropyl)-4-methylpiperazine End-capped Poly(1,4-butanediol diacrylate-co-4-amino-1-butanol)-based Multilayer Films for Gene Delivery

Cuicui Li, Stephany Y. Tzeng, Liane E. Tellier, Jordan J. Green

DNA-based therapeutics require an intracellular delivery system to be effective. For diseases like brain cancer—where local access to residual tumour is often available following surgical resection—an implantable device that enables both controlled release and intracellular delivery of DNA could open new…

Read the article
Molecular Therapy.2013ReviewNon-viral Gene Delivery

57. Endocytosis of Gene Delivery Vectors From Clathrin-dependent to Lipid Raft-mediated Endocytosis

El-Sayed A, Harashima H

Nonviral gene delivery vectors remain less efficient than viral vectors, and their intracellular fate is strongly influenced by the endocytic route they enter. The cell membrane is now understood to contain lipid raft and non-raft domains, and the initial binding domain can determine the primary endocytic vesicle…

Read the article
Journal of Controlled Release2013ReviewNon-viral Gene Delivery

58. Chitosan-based siRNA delivery systems

Ragelle, H.; Vandermeulen, G.; Préat, V

Chitosan is attractive for siRNA delivery because it is cationic, biocompatible, biodegradable, mucoadhesive, and permeation-enhancing. However, native chitosan suffers from low solubility at physiological pH, poor buffering capacity, instability in biological fluids, and insufficient endosomal escape, limiting…

Read the article
2012ReviewNon-viral Gene Delivery

59. Functional lipids and lipoplexes for improved gene delivery

Zhang X-X, Mcintosh Tj, Grinstaff Mw

Cationic lipids are the most common non-viral gene-delivery vectors, but they generally suffer from low transfection efficiency. Functional or stimulus-responsive lipids—especially pH-, redox-, and charge-reversal-sensitive lipids—may improve nucleic acid delivery by enabling triggered cargo release, endosomal…

Read the article
Journal of Controlled Release2011ResearchNon-viral Gene Delivery

60. Bioreducible Polymers with Cell Penetrating and Endosome Buffering Functionality for Gene Delivery Systems

Tae-Il Kim, Thomas Rothmund, Thomas Kissel, Sung Wan Kim

Endosomal escape remains a major barrier for polymeric gene delivery. Arginine-grafted bioreducible polymers (ABPs) show high transfection via cell-penetrating arginine, but the effect of adding endosome-buffering moieties on their biophysical and transfection properties was not well defined. Buffering capacity…

Read the article
Biomaterials2011ResearchNon-viral Gene Delivery

61. Polyethylenimine-grafted copolymer of poly(L-lysine) and poly(ethylene glycol) for gene delivery

Dai J, Zou S, Pei Y, Cheng D, Ai H, Shuai X

PEI is an effective gene carrier but high-molecular-weight PEI is nonbiodegradable and cytotoxic; PLL is biodegradable but lacks proton-buffering capacity, has low transfection efficiency, and is also cytotoxic. A vector combining the complementary strengths of PEI and PLL is needed. Cytotoxicity: At 100 µg/mL, PPL…

Read the article
Journal of Controlled Release2011ResearchNon-viral Gene Delivery

62. Revisit complexation between DNA and polyethylenimine — Effect of length of free polycationic chains on gene transfection

Yanan Yue, Fan Jin, Rui Deng, Jinge Cai, Zhuojun Dai, Marie C.M. Lin, Hsiang‐fu Kung, Maria Ahlm Mattebjerg, Thomas Lars Andresen, Chi Chung Wu

PEI is one of the best nonviral gene delivery vectors, but why it works so well remains unclear. In particular, the role of free, uncomplexed PEI chains and their length in transfection, cellular uptake, and endosomal escape has not been quantitatively resolved, and the “proton sponge” mechanism is increasingly…

Read the article
Biomaterials2011ResearchNon-viral Gene Delivery

63. Non-Viral Gene Delivery Nanoparticles Based on Poly(β-amino esters) for Treatment of Glioblastoma

Stephany Y. Tzeng, Hugo Guerrero‐cazares, Elliott E. Martinez, Joel C. Sunshine, Alfredo Quiñones‐hinojosa, Jordan J. Green

Glioblastoma (GB) has poor survival and current therapies are insufficient. Viral gene therapy carries safety risks, while nonviral vectors often lack efficiency and practical storage stability. PBAEs had shown high transfection and low toxicity in other cell types but had not been tested in primary brain tumour…

Read the article
2011ReviewNon-viral Gene Delivery

64. Strategies for the intracellular delivery of nanoparticles

Chou Lyt, Ming K, Chan Wcw.

Nanoparticles (NPs) are increasingly used as contrast agents, therapeutics, and delivery vehicles, but their effective delivery into cells and to specific subcellular organelles remains a major challenge. The review addresses fundamental barriers to intracellular NP delivery—plasma membrane, endosomal entrapment…

Read the article
Journal of Drug Delivery2011ReviewNon-viral Gene Delivery

65. Liposomes for Use in Gene Delivery

Daniel A. Balazs, W.T. Godbey

Liposomes are versatile, biocompatible vesicular carriers that can encapsulate and deliver DNA or RNA, but the relationship between lipid charge, lipid packing, and gene-delivery efficiency remains complex. This review discusses physical packing parameters and specific lipids used for gene delivery, classified by…

Read the article
2010ResearchNon-viral Gene Delivery

66. Cationic Lipid–Nucleic Acid Complexes for Gene Delivery and Silencing: Pathways and Mechanisms for Plasmid DNA and siRNA

Kai K. Ewert, Alexandra Zidovska, Ayesha Ahmad, Nathan F. Bouxsein, Heather M. Evans, Christopher S. Mcallister, Charles E. Samuel, Cyrus R. Safinya

Cationic lipid–nucleic acid (CL-NA) complexes are promising non-viral vectors for gene delivery and siRNA-mediated silencing, but their transfection and silencing efficiencies remain low compared with viral vectors. A major gap is poor mechanistic understanding of how complex structure, membrane charge density, and…

Read the article
International Journal of Pharmaceutics2010ResearchNon-viral Gene Delivery

67. DC-CholDOPE cationic liposomes A comparative study of the influence factors on plasmid pDNA and siRNA gene delivery

Zhang Y, Li H, Sun J, Gao J, Liu W, Li B, Guo Y, Chen J

DC-Chol/DOPE cationic liposomes are efficient non-viral vectors, but the effects of DC-Chol/DOPE molar ratio, PEGylation, and serum on pDNA versus siRNA delivery were unclear. The study also aimed to test whether pDNA and siRNA have different transfection mechanisms in these liposomes. Optimal DC-Chol/DOPE molar…

Read the article
Biomaterials2010ResearchNon-viral Gene Delivery

68. The Relationship Between Terminal Functionalization and Molecular Weight of a Gene Delivery Polymer and Transfection Efficacy in Mammary Epithelial 2-D Cultures and 3-D Organotypic Cultures

Nupura S. Bhise, Ryan S. Gray, Joel C. Sunshine, Soe Htet, Andrew J. Ewald, Jordan J. Green

Non-viral gene delivery vectors are safer alternatives to viral vectors but often suffer from low transfection efficiency, especially in hard-to-transfect primary cells and 3-D tissue models. There is a need to understand how small changes in polymer structure—specifically terminal functionalisation and molecular…

Read the article
Journal of Internal Medicine2010ReviewNon-viral Gene Delivery

69. Lipid-based nanotherapeutics for siRNA delivery

Schroeder A, Levins Cg, Cortez C, Langer R, Anderson Dg

RNAi has strong therapeutic potential, but clinical translation of siRNA is limited by delivery. siRNA is large, negatively charged, susceptible to nuclease degradation, poorly taken up by cells, and must reach the cytoplasm to engage RISC. Safe and effective lipid-based delivery systems are needed to protect siRNA…

Read the article
European Journal of Pharmaceutical Sciences2010ReviewNon-viral Gene Delivery

70. Gene delivery by lipoplexes and polyplexes

Conchita Tros De Ilarduya, Yan Sun, Nejat Düzgüneş

Viral vectors achieve high gene transfer efficiency but can induce immune/inflammatory responses, have limited DNA carrying capacity, and raise recombination and cost concerns. Non-viral vectors such as cationic lipids and polymers are safer alternatives, but their transfection efficiency—especially in vivo—remains…

Read the article
2009ReviewNon-viral Gene Delivery

71. Degradable Polymers for Gene Delivery

Sunshine, J.; Bhise, N.; Green, J. J

Non-viral gene delivery needs safe and effective carriers. PEI is effective but cytotoxic, while viral vectors raise safety concerns. Degradable poly(β-amino ester)s may provide effective gene delivery with reduced cytotoxicity. This study investigates how small changes in polymer synthesis ratio and end-group…

Read the article
International Journal of Pharmaceutics2008ResearchNon-viral Gene Delivery

72. Histidylated Cationic Polyorganophosphazene/DNA Self-Assembled Nanoparticles for Gene Delivery

Yongxin Yang, Zhenghong Xu, Shangwei Chen, Yu Gao, Wangwen Gu, Lingli Chen, Yuanying Pei, Yaping Li

Cationic polymers are widely studied non-viral gene vectors but generally show lower transfection efficiency than viral vectors. Endosomal escape is a major bottleneck. Histidine/imidazole-containing polymers can enhance gene expression via a “proton sponge” effect without increasing toxicity. Polyphosphazenes are…

Read the article
Articles — page 3 | Brilliant Blue Biosciences